Drugs / Ricrolin+
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03858036 Comparator | Mar 2019 → Dec 2024 | corneal ectasia, keratoconus | Center for Sight, Sacramento, CA | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ricrolin+ | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03858036 ↗ |
| Route | Topical | “1 to 2 drops of Ricrolin+ will be instilled topically in the eye every 2 minutes for 30 minutes.” NCT03858036 ↗ |